A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum - A progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03

被引:289
作者
Hyams, DM
Mamounas, EP
Petrelli, N
Rockette, H
Jones, J
Wieand, HS
Deutsch, M
Wickerham, DL
Fisher, B
Wolmark, N
机构
[1] UNIV PITTSBURGH,NATL SURG ADJUVANT BREAST & BOWEL PROJECT BIOSTAT,PITTSBURGH,PA
[2] UNIV PITTSBURGH,DEPT RADIAT ONCOL,PITTSBURGH,PA
[3] ROSWELL PK CANC CTR,DEPT SURG ONCOL,BUFFALO,NY
关键词
rectal neoplasms; colorectal neoplasms; drug therapy; radiotherapy; surgery; combined modality therapy; clinical trials;
D O I
10.1007/BF02054976
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: National Surgical Adjuvant Breast and Bowel Project Protocol R-03 was designed to determine the worth of preoperative chemotherapy and radiation therapy in the management of operable rectal cancer. METHODS: Thus far, 116 patients of an eventual 900 with primary operable rectal cancer have been randomized to receive multimodality therapy to begin preoperatively (59 patients) or identical therapy beginning after curative surgery (57). All patients received seven cycles of 5-fluorouracil (FU)/leucovorin (LV) chemotherapy. Cycles 1 and 4 through 7 used a high-dose weekly FU regimen. In Cycles 2 and 3, FU and low-dose LV chemotherapy was given during the first and fifth week of radiation therapy (5,040 cGy). The preoperative arm (Group 1) received the first three cycles of chemotherapy and all radiation therapy before surgery. The postoperative arm (Group 2) received all radiation and chemotherapy after surgery. Primary study end points included disease-free survival and survival. Secondary end points included local recurrence, primary tumor response to combination therapy, tumor downstaging, and sphincter preservation. RESULTS: Overall treatment-related toxicity was similar in both groups. Although seven preoperative patients had events after randomization that precluded surgery, eight events occurred during an equivalent follow-up period in the postoperative group. No patient was deemed inoperable because of progressive local disease. Sphincter-saving surgery was intended in 31 percent of Group 1 patients and 33 percent of Group 2 patients at the time of randomization. Such surgery was actually performed in 50 percent of the preoperatively treated patients and 33 percent of the postoperatively treated patients. The use of protective colostomy in patients undergoing sphincter-sparing surgery and the development of perioperative complications in all surgical patients were similar in both groups. There was evidence of tumor downstaging in evaluable patients undergoing preoperative therapy, with 8 percent of Group 1 patients having had a pathologic complete response. CONCLUSION: These data do suggest that the preoperative chemotherapy and radiation therapy regimen used are, at least, as safe and tolerable as standard postoperative treatment. There is presently a trend to tumor downstaging and sphincter preservation in the preoperative arm. Whether this arm will have greater or lesser survival and long-term toxicity awaits the completion of this relevant study.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 48 条
  • [1] ANDERSON BO, 1994, J AM COLL SURGEONS, V179, P513
  • [2] ROLE OF PREOPERATIVE IRRADIATION FOR ANAL PRESERVATION IN CANCER OF THE LOW RECTUM
    BERARD, P
    PAPILLON, J
    [J]. WORLD JOURNAL OF SURGERY, 1992, 16 (03) : 502 - 509
  • [3] CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO
  • [4] 2-I
  • [5] CEDERMARK B, 1994, MAR P ASCO, V13, P198
  • [6] DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO
  • [7] 2-T
  • [8] DUNCAN W, 1985, BRIT J SURG, V72, P559
  • [9] INFLUENCE OF IRRADIATION OF A PRIMARY TUMOR ON THE LABELING INDEX AND ESTROGEN-RECEPTOR INDEX IN A DISTANT TUMOR FOCUS
    FISHER, B
    SAFFER, EA
    DEUTSCH, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (06): : 879 - 885
  • [10] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01
    FISHER, B
    WOLMARK, N
    ROCKETTE, H
    REDMOND, C
    DEUTSCH, M
    WICKERHAM, DL
    FISHER, ER
    CAPLAN, R
    JONES, J
    LERNER, H
    GORDON, P
    FELDMAN, M
    CRUZ, A
    LEGAULTPOISSON, S
    WEXLER, M
    LAWRENCE, W
    ROBIDOUX, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01): : 21 - 29